Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 178

1.

Evaluation of New Tests and Interventions for Prostate Cancer Management: A Systematic Review.

Olleik G, Kassouf W, Aprikian A, Hu J, Vanhuyse M, Cury F, Peacock S, Bonnevier E, Palenius E, Dragomir A.

J Natl Compr Canc Netw. 2018 Nov;16(11):1340-1351. doi: 10.6004/jnccn.2018.7055.

PMID:
30442734
2.

Cost-utility of Sunitinib Versus Pazopanib in Metastatic Renal Cell Carcinoma in Canada using Real-world Evidence.

Nazha S, Tanguay S, Kapoor A, Jewett M, Kollmannsberger C, Wood L, Bjarnason GAG, Heng D, Soulières D, Reaume MN, Basappa N, Lévesque E, Dragomir A.

Clin Drug Investig. 2018 Sep 28. doi: 10.1007/s40261-018-0705-6. [Epub ahead of print]

PMID:
30267257
3.

Investigating the genetic profile of dopaminergic neurons in the VTA in response to perinatal nicotine exposure using mRNA-miRNA analyses.

Keller RF, Dragomir A, Yantao F, Akay YM, Akay M.

Sci Rep. 2018 Sep 13;8(1):13769. doi: 10.1038/s41598-018-31882-9.

4.

Training physicians in behavioural change counseling: A systematic review.

Dragomir AI, Julien CA, Bacon SL, Boucher VG, Lavoie KL; Canadian Network for Health Behavior Change and Promotion (CAN-Change).

Patient Educ Couns. 2018 Aug 19. pii: S0738-3991(18)30588-3. doi: 10.1016/j.pec.2018.08.025. [Epub ahead of print] Review.

PMID:
30172573
5.

A novel real-time driving fatigue detection system based on wireless dry EEG.

Wang H, Dragomir A, Abbasi NI, Li J, Thakor NV, Bezerianos A.

Cogn Neurodyn. 2018 Aug;12(4):365-376. doi: 10.1007/s11571-018-9481-5. Epub 2018 Feb 21.

PMID:
30137873
6.

Changes in the outcome of prostate biopsies after preventive task force recommendation against prostate-specific antigen screening.

Zakaria AS, Dragomir A, Brimo F, Kassouf W, Tanguay S, Aprikian A.

BMC Urol. 2018 Aug 20;18(1):69. doi: 10.1186/s12894-018-0384-x.

7.

A Network-Based Perspective in Alzheimer's Disease: Current State and an Integrative Framework.

Dragomir A, Vrahatis A, Bezerianos A.

IEEE J Biomed Health Inform. 2018 Aug 3. doi: 10.1109/JBHI.2018.2863202. [Epub ahead of print]

PMID:
30080151
8.

A misaligned magneto-optical trap to enable miniaturized atom chip systems.

Roy R, Rushton J, Dragomir A, Aldous M, Himsworth M.

Sci Rep. 2018 Jul 4;8(1):10095. doi: 10.1038/s41598-018-28464-0.

9.

Homozygosity for CREB3L1 premature stop codon in first case of recessive osteogenesis imperfecta associated with OASIS-deficiency to survive infancy.

Lindahl K, Åström E, Dragomir A, Symoens S, Coucke P, Larsson S, Paschalis E, Roschger P, Gamsjaeger S, Klaushofer K, Fratzl-Zelman N, Kindmark A.

Bone. 2018 Sep;114:268-277. doi: 10.1016/j.bone.2018.06.019. Epub 2018 Jun 22.

PMID:
29936144
10.

Will cognitive enhancement create post-persons? The use(lessness) of induction in determining the likelihood of moral status enhancement.

Mihailov E, Dragomir A.

Bioethics. 2018 Jun;32(5):308-313. doi: 10.1111/bioe.12437. Epub 2018 May 3.

PMID:
29726022
11.

Fronto-Parietal Subnetworks Flexibility Compensates For Cognitive Decline Due To Mental Fatigue.

Taya F, Dimitriadis SI, Dragomir A, Lim J, Sun Y, Wong KF, Thakor NV, Bezerianos A.

Hum Brain Mapp. 2018 Apr 24. doi: 10.1002/hbm.24192. [Epub ahead of print]

PMID:
29691949
12.

A cost-utility analysis of artificial urinary sphincter versus AdVance male sling in post prostatectomy stress urinary incontinence: A publicly funded health care perspective.

Shamout S, Nazha S, Dragomir A, Campeau L.

Neurourol Urodyn. 2018 Sep;37(7):2195-2203. doi: 10.1002/nau.23559. Epub 2018 Apr 10.

PMID:
29635704
13.

Changes in the levels of testosterone profile over time in relation to clinical parameters in a cohort of patients with prostate cancer managed by active surveillance.

Zakaria AS, Dragomir A, Kassouf W, Tanguay S, Aprikian A.

World J Urol. 2018 Aug;36(8):1209-1217. doi: 10.1007/s00345-018-2270-2. Epub 2018 Mar 20.

PMID:
29560520
14.

Investigating the Effect of Perinatal Nicotine Exposure on Dopaminergic Neurons in the VTA Using miRNA Expression Profiles.

Keller RF, Kanlikilicer P, Dragomir A, Fan Y, Akay YM, Akay M.

IEEE Trans Nanobioscience. 2017 Dec;16(8):843-849. doi: 10.1109/TNB.2017.2776841.

PMID:
29364128
15.

Tubular aggregates in congenital myasthenic syndrome.

Feresiadou A, Casar-Borota O, Dragomir A, Oldfors CH, Stålberg E, Oldfors A.

Neuromuscul Disord. 2018 Feb;28(2):174-175. doi: 10.1016/j.nmd.2017.11.009. Epub 2017 Nov 24. No abstract available.

PMID:
29311015
16.

Follow-up imaging after nephrectomy for cancer in Canada: urologists' compliance with guidelines. An observational study.

Dragomir A, Aprikian A, Kapoor A, Finelli A, Pouliot F, Rendon R, Black PC, Moore R, Breau RH, Kawakami J, Drachenberg D, Lattouf JB, Tanguay S.

CMAJ Open. 2017 Dec 11;5(4):E834-E841. doi: 10.9778/cmajo.20170005.

17.

Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients.

Niinivirta M, Enblad G, Edqvist PH, Pontén F, Dragomir A, Ullenhag GJ.

J Cancer. 2017 Oct 23;8(19):3975-3983. doi: 10.7150/jca.20889. eCollection 2017.

18.

Treatment-related survival associations of claudin-2 expression in fibroblasts of colorectal cancer.

Mezheyeuski A, Strell C, Hrynchyk I, Guren TK, Dragomir A, Doroshenko T, Pashkova O, Gorgun J, Ruksha K, Pfeiffer P, Kure EH, Sorbye H, Edler D, Martling A, Glimelius B, Östman A, Portyanko A.

Virchows Arch. 2018 Mar;472(3):395-405. doi: 10.1007/s00428-017-2263-3. Epub 2017 Nov 13.

19.

Genomic Gain of 16p13.3 in Prostate Cancer Predicts Poor Clinical Outcome after Surgical Intervention.

Bramhecha YM, Guérard KP, Rouzbeh S, Scarlata E, Brimo F, Chevalier S, Hamel L, Dragomir A, Aprikian AG, Lapointe J.

Mol Cancer Res. 2018 Jan;16(1):115-123. doi: 10.1158/1541-7786.MCR-17-0270. Epub 2017 Oct 9.

PMID:
28993510
20.

Comparison of Surgery and Radiation as Local Treatments in the Risk of Locoregional Complications in Men Subsequently Dying From Prostate Cancer.

Hu J, Aprikian AG, Cury FL, Vanhuyse M, Zakaria AS, Richard PO, Perreault S, Dragomir A.

Clin Genitourin Cancer. 2017 Sep 5. pii: S1558-7673(17)30266-5. doi: 10.1016/j.clgc.2017.08.011. [Epub ahead of print]

PMID:
28943330
21.

Pharmacological targeting of peptidylarginine deiminase 4 prevents cancer-associated kidney injury in mice.

Cedervall J, Dragomir A, Saupe F, Zhang Y, Ärnlöv J, Larsson E, Dimberg A, Larsson A, Olsson AK.

Oncoimmunology. 2017 Apr 20;6(8):e1320009. doi: 10.1080/2162402X.2017.1320009. eCollection 2017.

22.

Identification of mutations in SDR9C7 in six families with autosomal recessive congenital ichthyosis.

Hotz A, Fagerberg C, Vahlquist A, Bygum A, Törmä H, Rauschendorf MA, Zhang H, Heinz L, Bourrat E, Hausser I, Vestergaard V, Dragomir A, Zimmer AD, Fischer J.

Br J Dermatol. 2018 Mar;178(3):e207-e209. doi: 10.1111/bjd.15994. Epub 2018 Jan 21. No abstract available.

PMID:
28906551
23.

Treatment patterns and trends in patients dying of prostate cancer in Quebec: a population-based study.

Dragomir A, Rocha J, Vanhuyse M, Cury FL, Kassouf W, Hu J, Aprikian AG.

Curr Oncol. 2017 Aug;24(4):240-248. doi: 10.3747/co.24.3598. Epub 2017 Aug 31.

24.

High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer.

Siesing C, Sorbye H, Dragomir A, Pfeiffer P, Qvortrup C, Pontén F, Jirström K, Glimelius B, Eberhard J.

PLoS One. 2017 Aug 11;12(8):e0182512. doi: 10.1371/journal.pone.0182512. eCollection 2017.

25.

Carrier frequency modulation of an acousto-optic modulator for laser stabilization.

Aldous M, Woods J, Dragomir A, Roy R, Himsworth M.

Opt Express. 2017 May 29;25(11):12830-12838. doi: 10.1364/OE.25.012830.

PMID:
28786635
26.

Contemporary cost-consequence analysis of blue light cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer.

Klaassen Z, Li K, Kassouf W, Black PC, Dragomir A, Kulkarni GS.

Can Urol Assoc J. 2017 Jun;11(6):173-181. doi: 10.5489/cuaj.4568.

27.

Health care services utilization during the last 6 months of life among patients with bladder cancer who underwent radical cystectomy in Quebec, Canada.

Zakaria AS, Santos F, Dragomir A, Kassouf W, Tanguay S, Aprikian A.

Urol Oncol. 2017 Sep;35(9):539.e1-539.e7. doi: 10.1016/j.urolonc.2017.04.005. Epub 2017 May 4.

PMID:
28479117
28.

Impact of abiraterone acetate with and without prior docetaxel chemotherapy on the survival of patients with metastatic castration-resistant prostate cancer: a population-based study.

Rocha J, Aprikian AG, Vanhuyse M, Cury FL, Hu J, Prévost N, Dragomir A.

CMAJ Open. 2017 Mar 28;5(1):E265-E272. doi: 10.9778/cmajo.20160082. eCollection 2017 Jan-Mar.

29.

Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib.

Niinivirta M, Enblad G, Edqvist PH, Pontén F, Dragomir A, Ullenhag GJ.

J Cancer Res Clin Oncol. 2017 Jun;143(6):961-970. doi: 10.1007/s00432-017-2365-y. Epub 2017 Mar 4.

30.

Asporin is a stromally expressed marker associated with prostate cancer progression.

Rochette A, Boufaied N, Scarlata E, Hamel L, Brimo F, Whitaker HC, Ramos-Montoya A, Neal DE, Dragomir A, Aprikian A, Chevalier S, Thomson AA.

Br J Cancer. 2017 Mar 14;116(6):775-784. doi: 10.1038/bjc.2017.15. Epub 2017 Feb 2.

31.

Ventral Tegmental Area Dopamine Neurons Firing Model Reveals Prenatal Nicotine Induced Alterations.

Dragomir A, Akay YM, Zhang D, Akay M.

IEEE Trans Neural Syst Rehabil Eng. 2017 Sep;25(9):1387-1396. doi: 10.1109/TNSRE.2016.2636133. Epub 2016 Dec 6.

PMID:
28114025
32.

[Social cognition disorders in Klinefelter syndrome: A specific phenotype? (KS)].

Babinet MN, Rigard C, Peyroux É, Dragomir AR, Plotton I, Lejeune H, Demily C.

Encephale. 2017 Oct;43(5):423-428. doi: 10.1016/j.encep.2016.04.010. Epub 2016 Oct 13. French.

PMID:
27743676
33.

Gene expression profiling of midbrain dopamine neurons upon gestational nicotine exposure.

Kanlikilicer P, Zhang D, Dragomir A, Akay YM, Akay M.

Med Biol Eng Comput. 2017 Mar;55(3):467-482. doi: 10.1007/s11517-016-1531-8. Epub 2016 Jun 2.

PMID:
27255453
34.

Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer.

Mezheyeuski A, Bradic Lindh M, Guren TK, Dragomir A, Pfeiffer P, Kure EH, Ikdahl T, Skovlund E, Corvigno S, Strell C, Pietras K, Ponten F, Mulder J, Qvortrup C, Portyanko A, Tveit KM, Glimelius B, Sorbye H, Östman A.

Oncotarget. 2016 Jul 5;7(27):41948-41958. doi: 10.18632/oncotarget.9632.

35.

Assessing Antidepressants Using Intelligent Data Monitoring and Mining of Online Fora.

Akay A, Dragomir A, Erlandsson BE.

IEEE J Biomed Health Inform. 2016 Jul;20(4):977-86. doi: 10.1109/JBHI.2016.2539972. Epub 2016 May 3.

PMID:
27164611
36.

Management of localized and advanced prostate cancer in Canada: A lifetime cost and quality-adjusted life-year analysis.

Sanyal C, Aprikian AG, Cury FL, Chevalier S, Dragomir A.

Cancer. 2016 Apr 1;122(7):1085-96. doi: 10.1002/cncr.29892. Epub 2016 Feb 1.

37.

Predictors of costs associated with radical cystectomy for bladder cancer: A population-based retrospective cohort study in the province of Quebec, Canada.

Santos F, Dragomir A, Zakaria AS, Kassouf W, Aprikian A.

J Surg Oncol. 2016 Feb;113(2):223-8. doi: 10.1002/jso.24132. Epub 2015 Dec 22.

PMID:
26696270
38.

Delta-24-RGD Induces Cytotoxicity of Glioblastoma Spheroids in Three Dimensional PEG Microwells.

Avci NG, Fan Y, Dragomir A, Akay YM, Gomez-Manzano C, Fueyo-Margareto J, Akay M.

IEEE Trans Nanobioscience. 2015 Dec;14(8):946-51. doi: 10.1109/TNB.2015.2499312. Epub 2015 Dec 4.

PMID:
26661633
39.

Cost-effectiveness of multiparametric magnetic resonance imaging and targeted biopsy in diagnosing prostate cancer.

Cerantola Y, Dragomir A, Tanguay S, Bladou F, Aprikian A, Kassouf W.

Urol Oncol. 2016 Mar;34(3):119.e1-9. doi: 10.1016/j.urolonc.2015.09.010. Epub 2015 Oct 24.

PMID:
26602178
40.

Investigating the Influence of HUVECs in the Formation of Glioblastoma Spheroids in High-Throughput Three-Dimensional Microwells.

Avci NG, Fan Y, Dragomir A, Akay YM, Akay M.

IEEE Trans Nanobioscience. 2015 Oct;14(7):790-6. doi: 10.1109/TNB.2015.2477818. Epub 2015 Nov 11.

PMID:
26571536
41.

Whole-exome sequencing identifies novel autosomal recessive DSG1 mutations associated with mild SAM syndrome.

Schlipf NA, Vahlquist A, Teigen N, Virtanen M, Dragomir A, Fismen S, Barenboim M, Manke T, Rösler B, Zimmer A, Fischer J.

Br J Dermatol. 2016 Feb;174(2):444-8. doi: 10.1111/bjd.14079. Epub 2015 Nov 19. No abstract available.

PMID:
26288349
42.

Health-care services utilization and costs associated with radical cystectomy for bladder cancer: a descriptive population-based study in the province of Quebec, Canada.

Santos F, Dragomir A, Zakaria AS, Kassouf W, Aprikian A.

BMC Health Serv Res. 2015 Aug 5;15:308. doi: 10.1186/s12913-015-0972-3.

43.

High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Metastatic Colorectal Cancer Cohort.

Sorbye H, Dragomir A, Sundström M, Pfeiffer P, Thunberg U, Bergfors M, Aasebø K, Eide GE, Ponten F, Qvortrup C, Glimelius B.

PLoS One. 2015 Jun 29;10(6):e0131046. doi: 10.1371/journal.pone.0131046. eCollection 2015.

44.

Application of the Abridged SimSmoke model to four Eastern Mediterranean countries.

Levy DT, Fouad H, Levy J, Dragomir AD, El Awa F.

Tob Control. 2016 Jul;25(4):413-21. doi: 10.1136/tobaccocontrol-2015-052334. Epub 2015 Jun 16.

45.

Urologist referral delay and its impact on survival after radical cystectomy for bladder cancer.

Santos F, Dragomir A, Kassouf W, Franco E, Aprikian A.

Curr Oncol. 2015 Feb;22(1):e20-6. doi: 10.3747/co.22.2052.

46.

β-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis.

Kocabayoglu P, Lade A, Lee YA, Dragomir AC, Sun X, Fiel MI, Thung S, Aloman C, Soriano P, Hoshida Y, Friedman SL.

J Hepatol. 2015 Jul;63(1):141-7. doi: 10.1016/j.jhep.2015.01.036. Epub 2015 Feb 9.

47.

A novel data-mining approach leveraging social media to monitor consumer opinion of sitagliptin.

Akay A, Dragomir A, Erlandsson BE.

IEEE J Biomed Health Inform. 2015 Jan;19(1):389-96. doi: 10.1109/JBHI.2013.2295834.

PMID:
25561458
48.

Engineering a High-Throughput 3-D In Vitro Glioblastoma Model.

Fan Y, Avci NG, Nguyen DT, Dragomir A, Akay YM, Xu F, Akay M.

IEEE J Transl Eng Health Med. 2015 Mar 5;3:4300108. doi: 10.1109/JTEHM.2015.2410277. eCollection 2015.

49.

Clinical management and burden of prostate cancer: a Markov Monte Carlo model.

Sanyal C, Aprikian A, Cury F, Chevalier S, Dragomir A.

PLoS One. 2014 Dec 4;9(12):e113432. doi: 10.1371/journal.pone.0113432. eCollection 2014.

50.

Sex differences in the prediction of metabolic burden from physiological responses to stress.

Gentile C, Dragomir AI, Solomon C, Nigam A, D'Antono B.

Ann Behav Med. 2015 Feb;49(1):112-27. doi: 10.1007/s12160-014-9639-2.

PMID:
25228454

Supplemental Content

Loading ...
Support Center